0001209191-18-046476.txt : 20180813
0001209191-18-046476.hdr.sgml : 20180813
20180813174130
ACCESSION NUMBER: 0001209191-18-046476
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180809
FILED AS OF DATE: 20180813
DATE AS OF CHANGE: 20180813
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jaen Juan C.
CENTRAL INDEX KEY: 0001422996
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38419
FILM NUMBER: 181013522
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcus Biosciences, Inc.
CENTRAL INDEX KEY: 0001724521
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473898435
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3928 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: 650-489-9000
MAIL ADDRESS:
STREET 1: 3928 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-08-09
0
0001724521
Arcus Biosciences, Inc.
RCUS
0001422996
Jaen Juan C.
3928 POINT EDEN WAY
HAYWARD
CA
94545
1
1
0
0
President
Common Stock
2018-08-09
4
P
0
4262
11.9323
A
2738502
I
By Trust
Common Stock
2018-08-10
4
P
0
2579
11.9412
A
2741081
I
By Trust
Common Stock
2018-08-13
4
P
0
3159
11.7658
A
2744240
I
By Trust
Common Stock
189393
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.41 to $12.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.87 to $12.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.61 to $11.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
/s/ Scott Paraker, Attorney-in-Fact
2018-08-13